AdaptHealth Corp. (AHCO) vs Sana Biotechnology, Inc. (SANA)

A side-by-side comparison of AdaptHealth Corp. and Sana Biotechnology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AHCO vs SANA

growth of $100 · dividends reinvested · last 6y
AHCO -84.1% (-26.4%/yr)SANA -91.8% (-34.1%/yr)AHCO compounded faster over this window
050100Start $10020222023202420252026$16$8
AHCO SANA

AHCO vs SANA: by the numbers

  • •AHCO is the larger company ($788M vs $772M market cap).
  • •Both run net losses; SANA's is the smaller (0.00% vs -7.58% net margin).

Metrics side by side

Valuation

MetricAHCOSANA
P/S ratio0.26N/A
P/B ratio0.575.00
EV / EBITDA6.64N/A
FCF yield12.39%N/A

Profitability

MetricAHCOSANA
Gross margin10.37%0.00%
Operating margin-0.31%0.00%
Net margin-7.58%0.00%
ROE-16.56%-137.04%
ROIC-0.26%-67.58%

Growth (annualized)

MetricAHCOSANA
Revenue CAGR (5Y)11.68%N/A
FCF CAGR (5Y)7.07%N/A
Total return CAGR (5Y)-24.65%-32.33%

Frequently asked

How have AHCO and SANA total returns compared?
Over the past 5 years, AHCO delivered -24.65% and SANA delivered -32.33% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.